Objective: Cardiac surgery during pregnancy often carries a high risk of death for both mother and baby. Herein, we report our
experience of valvular surgery in pregnant patients. Methods: We retrospectively reviewed the cases of all pregnant patients that had
valvular surgery performed on them between 1998 and 2018 at the Ho Chi Minh City Heart Institute, Viet Nam. Both fetal and
maternal outcomes have been assessed to determine the effectiveness of surgical treatment. Results: The total number of patients
was 63, including 27 patients who had valvuloplasty and 36 patients who had valvular replacement. The maternal and fetal mortality
rates were 4.7% and 14.3% respectively. Adverse maternal outcomes occurred in 25% of patients (n=16), including low cardiac
output, cardiac arrhythmia, and acute pulmonary edema. Adverse fetal outcomes occurred in 41.2% of patients (n=26) including
termination by cesarean (4), miscarriage (5), threatened abortion (12), pre-term delivery (3), and still birth (2). Factors that affect
maternal mortality include pre-operative NYHA (p= 0.037) and the type of operation (p =0.034). Factors that affected fetal mortality
included cardiopulmonary bypass time (p = 0.003) and clamp time (p= 0.01). The average follow-up was 103.94 ± 73.9 months
(range 1- 259) with 95% completion of follow-up. Conclusions: Surgical treatment for pregnant patients with valvular heart disease
remains a challenge. The coordination of many medical specialists, the use of CPB and the timing of surgery should be optimized
where possible to achieve the best outcomes for both mother and fetus.
Keywords: pregnancy, valvular surgery, feto-maternal outcomes